Paul Tudor Jones’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-17,820
| Closed | -$172K | – | 4041 |
|
|
2026
Q1 | $132K | Sell |
17,820
-138,822
| -89% | -$1.46M | ﹤0.01% | 3437 |
|
|
2025
Q4 | $1.84M | Sell |
156,642
-218,709
| -58% | -$2.36M | ﹤0.01% | 1861 |
|
|
2025
Q3 | $2.9M | Sell |
375,351
-320,361
| -46% | -$2.24M | 0.01% | 1558 |
|
|
2025
Q2 | $5.09M | Buy |
695,712
+580,491
| +504% | +$4.68M | 0.01% | 1077 |
|
|
2025
Q1 | $1.09M | Buy |
115,221
+27,868
| +32% | +$348K | ﹤0.01% | 1757 |
|
|
2024
Q4 | $1.44M | Sell |
87,353
-129,945
| -60% | -$2.02M | 0.01% | 1470 |
|
|
2024
Q3 | $3.21M | Buy |
217,298
+67,490
| +45% | +$1.06M | 0.01% | 936 |
|
|
2024
Q2 | $2.08M | Buy |
+149,808
| New | +$2.12M | 0.01% | 1040 |
|
|
2024
Q1 | – | Sell |
-28,844
| Closed | -$467K | – | 2596 |
|
|
2023
Q4 | $467K | Buy |
+28,844
| New | +$472K | ﹤0.01% | 1829 |
|
|
2023
Q3 | – | Sell |
-165,391
| Closed | -$2.66M | – | 2671 |
|
|
2023
Q2 | $2.66M | Buy |
165,391
+32,889
| +25% | +$542K | 0.03% | 737 |
|
|
2023
Q1 | $2.31M | Buy |
132,502
+18,293
| +16% | +$261K | 0.04% | 716 |
|
|
2022
Q4 | $1.05M | Buy |
114,209
+58,779
| +106% | +$548K | 0.02% | 1066 |
|
|
2022
Q3 | $477K | Buy |
+55,430
| New | +$550K | 0.01% | 1439 |
|
|
2022
Q2 | – | Sell |
-24,768
| Closed | -$301K | – | 2378 |
|
|
2022
Q1 | $301K | Buy |
+24,768
| New | +$521K | 0.01% | 1554 |
|
|
2021
Q2 | – | Sell |
-11,000
| Closed | -$531K | – | 1818 |
|
|
2021
Q1 | $531K | Buy |
+11,000
| New | +$573K | 0.01% | 1118 |
|
|
2019
Q1 | – | Sell |
-77,896
| Closed | -$982K | – | 1219 |
|
|
2018
Q4 | $982K | Buy |
77,896
+32,884
| +73% | +$490K | 0.02% | 396 |
|
|
2018
Q3 | $691K | Buy |
45,012
+3,470
| +8% | +$48K | 0.02% | 573 |
|
|
2018
Q2 | $545K | Buy |
41,542
+25,162
| +154% | +$277K | 0.02% | 643 |
|
|
2018
Q1 | $134K | Buy |
+16,380
| New | +$133K | ﹤0.01% | 906 |
|
|
2017
Q2 | – | Sell |
-45,632
| Closed | -$360K | – | 1262 |
|
|
2017
Q1 | $360K | Buy |
45,632
+18,762
| +70% | +$153K | 0.01% | 885 |
|
|
2016
Q4 | $230K | Buy |
26,870
+15,927
| +146% | +$136K | 0.01% | 1159 |
|
|
2016
Q3 | $90K | Sell |
10,943
-3,236
| -23% | -$27.2K | ﹤0.01% | 1346 |
|
|
2016
Q2 | $114K | Buy |
+14,179
| New | +$114K | ﹤0.01% | 1507 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Paul Tudor Jones's NEO Position: Q2 2026 in Review
Paul Tudor Jones sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 17,820 shares — an estimated $172K sold.
Paul Tudor Jones first reported a position in NEO in Q2 2016 and held it in 23 quarters. The position peaked at $5.09M in Q2 2025. 265 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Paul Tudor Jones reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
- Paul Tudor Jones sold 17,820 NeoGenomics shares in Q2 2026, an estimated $172K.
- Paul Tudor Jones first reported a position in NeoGenomics in Q2 2016 and held it in 23 quarters.
- Paul Tudor Jones's NeoGenomics position peaked at $5.09M in Q2 2025.
- 265 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.